Latest News and Press Releases
Want to stay updated on the latest news?
-
Ad hoc-Mitteilung gemäss Art. 53 KR Pratteln, Schweiz, 15. August 2025 – Santhera Pharmaceuticals (SIX: SANN) gibt bekannt, dass das Unternehmen und Highbridge Capital Management, LLC (Highbridge)...
-
Ad hoc announcement pursuant to Art. 53 LRA Pratteln, Switzerland, 15 August, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces that by mutual agreement the Company and Highbridge Capital...